
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | $237.7M | $458.2M | $677.4M | $729.6M | $735.6M | |
Revenue Growth (YoY) | -71.04% | 92.79% | 47.82% | 7.7% | 0.82% | |
Cost of Revenues | $186.5M | $274.5M | $420M | $443M | $448.2M | |
Gross Profit | $51.1M | $183.7M | $257.4M | $286.5M | $287.4M | |
Gross Profit Margin | 21.52% | 40.1% | 38% | 39.28% | 39.07% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $89M | $105M | $124.7M | $127.6M | $139.4M | |
Other Inc / (Exp) | -$25.8M | -$4.6M | $3.5M | -$616K | -$22.2M | |
Operating Expenses | $204.9M | $219.4M | $247.6M | $251.6M | $264.4M | |
Operating Income | -$153.7M | -$35.7M | $9.8M | $35M | $23M | |
Net Interest Expenses | $16.3M | $18.7M | $15.3M | $12.7M | $11M | |
EBT. Incl. Unusual Items | -$195.8M | -$59M | -$2M | $21.7M | -$10.2M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -$70.9M | -$15.7M | $7.1M | $6.9M | -$2.4M | |
Net Income to Company | -$124.9M | -$43.3M | -$9.1M | $14.8M | -$7.8M | |
Minority Interest in Earnings | $23K | -- | -$2.9M | -- | -- | |
Net Income to Common Excl Extra Items | -$124.8M | -$43.3M | -$12M | $14.8M | -$7.8M | |
Basic EPS (Cont. Ops) | -$4.13 | -$1.42 | -$0.39 | $0.48 | -$0.25 | |
Diluted EPS (Cont. Ops) | -$4.13 | -$1.42 | -$0.39 | $0.46 | -$0.25 | |
Weighted Average Basic Share | $31M | $31.4M | $31.5M | $31.7M | $31.9M | |
Weighted Average Diluted Share | $31M | $31.4M | $31.5M | $41M | $31.9M | |
EBITDA | -$104.5M | $31.8M | $80.4M | $101.7M | $68.7M | |
EBIT | -$179.5M | -$40.3M | $13.3M | $34.4M | $763K | |
Revenue (Reported) | $237.7M | $458.2M | $677.4M | $729.6M | $735.6M | |
Operating Income (Reported) | -$153.7M | -$35.7M | $9.8M | $35M | $23M | |
Operating Income (Adjusted) | -$179.5M | -$40.3M | $13.3M | $34.4M | $763K |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $50.8M | $132.2M | $152.3M | $138.5M | $148.8M | |
Revenue Growth (YoY) | -68.15% | 160.39% | 15.15% | -9.02% | 7.38% | |
Cost of Revenues | $36.7M | $87.6M | $99.2M | $92.3M | $101.5M | |
Gross Profit | $14.1M | $44.7M | $53.1M | $46.2M | $47.3M | |
Gross Profit Margin | 27.67% | 33.78% | 34.87% | 33.36% | 31.76% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $22.2M | $29.8M | $31.4M | $33.1M | $36.2M | |
Other Inc / (Exp) | $1.6M | -$562K | -$710K | -$59K | $425K | |
Operating Expenses | $49.7M | $61.5M | $61.7M | $62.9M | $69M | |
Operating Income | -$35.7M | -$16.8M | -$8.6M | -$16.6M | -$21.8M | |
Net Interest Expenses | $4.8M | $4.1M | $3M | $2.5M | $2.8M | |
EBT. Incl. Unusual Items | -$38.9M | -$21.5M | -$12.3M | -$19.2M | -$24.2M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -$10.8M | -$6.5M | -$2.8M | -$7.4M | -$7.4M | |
Net Income to Company | -$28.1M | -$14.9M | -$9.5M | -$11.9M | -$16.8M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$28.1M | -$14.9M | -$9.5M | -$11.9M | -$16.8M | |
Basic EPS (Cont. Ops) | -$0.93 | -$0.48 | -$0.31 | -$0.38 | -$0.54 | |
Diluted EPS (Cont. Ops) | -$0.93 | -$0.48 | -$0.31 | -$0.38 | -$0.54 | |
Weighted Average Basic Share | $31.2M | $31.4M | $31.6M | $31.9M | $31.6M | |
Weighted Average Diluted Share | $31.2M | $31.4M | $31.6M | $31.9M | $31.6M | |
EBITDA | -$16.1M | -$128K | $6.6M | -$686K | -$3.5M | |
EBIT | -$34M | -$17.4M | -$9.3M | -$16.7M | -$21.4M | |
Revenue (Reported) | $50.8M | $132.2M | $152.3M | $138.5M | $148.8M | |
Operating Income (Reported) | -$35.7M | -$16.8M | -$8.6M | -$16.6M | -$21.8M | |
Operating Income (Adjusted) | -$34M | -$17.4M | -$9.3M | -$16.7M | -$21.4M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $129M | $539.7M | $697.4M | $715.8M | $745.8M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $114.2M | $325.3M | $431.6M | $436.2M | $457.4M | |
Gross Profit | $14.8M | $214.4M | $265.8M | $279.7M | $288.4M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $81.1M | $112.6M | $126.3M | $129.2M | $142.6M | |
Other Inc / (Exp) | -$14.1M | -$6.8M | $3.4M | $35K | -$21.7M | |
Operating Expenses | $190.8M | $231.2M | $247.8M | $252.7M | $270.5M | |
Operating Income | -$175.9M | -$16.8M | $18M | $26.9M | $17.9M | |
Net Interest Expenses | $18.6M | $18M | $14.2M | $12.2M | $11.3M | |
EBT. Incl. Unusual Items | -$208.6M | -$41.6M | $7.2M | $14.7M | -$15.1M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -$75.1M | -$11.5M | $10.8M | $2.3M | -$2.4M | |
Net Income to Company | -$133.5M | -$30.1M | -$3.7M | $12.4M | -$12.7M | |
Minority Interest in Earnings | -$125K | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$133.6M | -$30.1M | -$6.5M | $12.4M | -$12.7M | |
Basic EPS (Cont. Ops) | -$4.38 | -$0.98 | -$0.21 | $0.39 | -$0.41 | |
Diluted EPS (Cont. Ops) | -$4.41 | -$1.00 | -$0.27 | $0.24 | -$0.42 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | -$116M | $47.8M | $87.1M | $94.4M | $65.9M | |
EBIT | -$190M | -$23.6M | $21.4M | $27M | -$3.9M | |
Revenue (Reported) | $129M | $539.7M | $697.4M | $715.8M | $745.8M | |
Operating Income (Reported) | -$175.9M | -$16.8M | $18M | $26.9M | $17.9M | |
Operating Income (Adjusted) | -$190M | -$23.6M | $21.4M | $27M | -$3.9M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $50.8M | $132.2M | $152.3M | $138.5M | $148.8M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $36.7M | $87.6M | $99.2M | $92.3M | $101.5M | |
Gross Profit | $14.1M | $44.7M | $53.1M | $46.2M | $47.3M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $22.2M | $29.8M | $31.4M | $33.1M | $36.2M | |
Other Inc / (Exp) | $1.6M | -$562K | -$710K | -$59K | $425K | |
Operating Expenses | $49.7M | $61.5M | $61.7M | $62.9M | $69M | |
Operating Income | -$35.7M | -$16.8M | -$8.6M | -$16.6M | -$21.8M | |
Net Interest Expenses | $4.8M | $4.1M | $3M | $2.5M | $2.8M | |
EBT. Incl. Unusual Items | -$38.9M | -$21.5M | -$12.3M | -$19.2M | -$24.2M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -$10.8M | -$6.5M | -$2.8M | -$7.4M | -$7.4M | |
Net Income to Company | -$28.1M | -$14.9M | -$9.5M | -$11.9M | -$16.8M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$28.1M | -$14.9M | -$9.5M | -$11.9M | -$16.8M | |
Basic EPS (Cont. Ops) | -$0.93 | -$0.48 | -$0.31 | -$0.38 | -$0.54 | |
Diluted EPS (Cont. Ops) | -$0.93 | -$0.48 | -$0.31 | -$0.38 | -$0.54 | |
Weighted Average Basic Share | $31.2M | $31.4M | $31.6M | $31.9M | $31.6M | |
Weighted Average Diluted Share | $31.2M | $31.4M | $31.6M | $31.9M | $31.6M | |
EBITDA | -$16.1M | -$128K | $6.6M | -$686K | -$3.5M | |
EBIT | -$34M | -$17.4M | -$9.3M | -$16.7M | -$21.4M | |
Revenue (Reported) | $50.8M | $132.2M | $152.3M | $138.5M | $148.8M | |
Operating Income (Reported) | -$35.7M | -$16.8M | -$8.6M | -$16.6M | -$21.8M | |
Operating Income (Adjusted) | -$34M | -$17.4M | -$9.3M | -$16.7M | -$21.4M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $6.7M | $17.7M | $21.7M | $55.6M | $40.8M | |
Short Term Investments | $1.4M | $4.6M | $3.9M | $5.4M | $8.1M | |
Accounts Receivable, Net | $405K | $9M | $6.7M | $7.6M | $6.9M | |
Inventory | $3.4M | $4.9M | $5.7M | $5.9M | $7M | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | $5.6M | $5.8M | $7.9M | $19.2M | $18.5M | |
Total Current Assets | $67.8M | $99.9M | $63.9M | $110M | $100.9M | |
Property Plant And Equipment | $1.1B | $988.3M | $910.7M | $862.1M | $844.9M | |
Long-Term Investments | $2.1M | $2.3M | $2.1M | $1.7M | $5.2M | |
Goodwill | $75.2M | $75.1M | $75M | $75M | $75M | |
Other Intangibles | $7.3M | $7M | $6.9M | $6.9M | $6.9M | |
Other Long-Term Assets | $23.8M | $5.7M | $5.9M | $9.4M | $7.7M | |
Total Assets | $1.3B | $1.2B | $1.1B | $1.1B | $1B | |
Accounts Payable | $13.2M | $35.8M | $32.2M | $37.4M | $50.7M | |
Accrued Expenses | $58.2M | $59.7M | $56.3M | $57.7M | $53.8M | |
Current Portion Of Long-Term Debt | $97.7M | $58.3M | $10.4M | $10.3M | $10.1M | |
Current Portion Of Capital Lease Obligations | $22.4M | $19.4M | $17M | $17.9M | $18.4M | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | $217.4M | $213.2M | $156.4M | $164.4M | $176.7M | |
Long-Term Debt | $193M | $204.2M | $170M | $159.5M | $149M | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $755.5M | $734.7M | $607.7M | $593.9M | $579.7M | |
Common Stock | $31.2M | $31.5M | $31.6M | $31.8M | $32.2M | |
Other Common Equity Adj | -$14.9M | -$11.4M | -$1.7M | -$1.3M | -$181K | |
Common Equity | $498.7M | $453.6M | $456.1M | $471.2M | $464.9M | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | $824K | -- | -- | |
Total Equity | $498.7M | $453.6M | $456.9M | $471.2M | $464.9M | |
Total Liabilities and Equity | $1.3B | $1.2B | $1.1B | $1.1B | $1B | |
Cash and Short Terms | $8.2M | $22.3M | $25.6M | $61M | $49M | |
Total Debt | $290.8M | $262.5M | $180.4M | $169.9M | $159.1M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $6M | $19.4M | $10.1M | $17.3M | $11.9M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $6.6M | $21.4M | $19.6M | $13.4M | $18.3M | |
Inventory | -- | -- | -- | -- | -- | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | $10.7M | $17.2M | $20M | $24.6M | $25.8M | |
Total Current Assets | $63.7M | $64.7M | $52.9M | $61.5M | $59.8M | |
Property Plant And Equipment | $1.1B | $972.6M | $899M | $851.3M | $849.6M | |
Long-Term Investments | -- | $2.2M | $1.9M | $5.5M | $4.5M | |
Goodwill | $75.2M | $75.1M | $75M | $75M | $75M | |
Other Intangibles | -- | -- | -- | -- | -- | |
Other Long-Term Assets | $30.9M | $12.5M | $12.9M | $24.1M | $22.6M | |
Total Assets | $1.2B | $1.1B | $1B | $1B | $1B | |
Accounts Payable | $13.3M | $23.8M | $29.1M | $29.6M | $25.9M | |
Accrued Expenses | $56.3M | $56.7M | $54.2M | $56.9M | $57.2M | |
Current Portion Of Long-Term Debt | $94.6M | $57.6M | $10.3M | $10.3M | $9.8M | |
Current Portion Of Capital Lease Obligations | $21.6M | $18.4M | $17M | $16.7M | $18.5M | |
Other Current Liabilities | -- | -- | -- | -- | $72M | |
Total Current Liabilities | $210.6M | $186.4M | $140.1M | $141.9M | $142.8M | |
Long-Term Debt | $227.8M | $203.9M | $178.9M | $159.5M | $189.1M | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $768M | $697.5M | $593.3M | $558.8M | $576.2M | |
Common Stock | $31.5M | $31.6M | $31.8M | $32.2M | $32.4M | |
Other Common Equity Adj | -$14.5M | -$10.9M | -$1.8M | -$1.3M | -$185K | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | $274K | -- | -- | |
Total Equity | $457.9M | $441.8M | $448.4M | $459.3M | $441.8M | |
Total Liabilities and Equity | $1.2B | $1.1B | $1B | $1B | $1B | |
Cash and Short Terms | $6M | $19.4M | $10.1M | $17.3M | $11.9M | |
Total Debt | $322.4M | $261.5M | $189.3M | $169.8M | $198.9M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$124.9M | -$43.3M | -$9.1M | $14.8M | -$7.8M | |
Depreciation & Amoritzation | $75.1M | $72.1M | $67.1M | $67.3M | $68M | |
Stock-Based Compensation | $4.4M | $9.3M | $8.2M | $6.4M | $8.2M | |
Change in Accounts Receivable | $18.2M | -$21.5M | $11.2M | $1.9M | -$1.8M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -$68.6M | $46.3M | $93.2M | $102.6M | $103.9M | |
Capital Expenditures | $21.4M | $17.1M | $36.8M | $38.8M | $79.2M | |
Cash Acquisitions | -$28K | -$2.4M | $31.1M | -- | -$4.1M | |
Cash From Investing | -$12.1M | $10.9M | -$346K | -$36.7M | -$81.9M | |
Dividends Paid (Ex Special Dividend) | -$5.1M | -- | -$3.1M | -$7.4M | -$8.8M | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $415.8M | $185.2M | $100M | $38M | $219M | |
Long-Term Debt Repaid | -$316.9M | -$232.3M | -$185.9M | -$58.7M | -$256.4M | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -$24.5M | -$208K | -$2.1M | -$2.2M | $17.2M | |
Cash From Financing | $69.1M | -$47.2M | -$92.4M | -$30.5M | -$37.3M | |
Beginning Cash (CF) | $25.6M | $14.1M | $24.1M | $24.5M | $59.8M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$11.5M | $10M | $452K | $35.3M | -$15.3M | |
Ending Cash (CF) | $14.1M | $24.1M | $24.5M | $59.8M | $44.6M | |
Levered Free Cash Flow | -$89.9M | $29.2M | $56.4M | $63.9M | $24.7M |
Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$23.4M | $9M | $13.5M | -$20.2M | -- | |
Depreciation & Amoritzation | $18.5M | $16.8M | $16M | $16.7M | -- | |
Stock-Based Compensation | $2.7M | $1.7M | $1.5M | $2.4M | -- | |
Change in Accounts Receivable | -$4.7M | -$4.9M | -$1M | -$7M | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $3.3M | $48.8M | $55.1M | $36M | -- | |
Capital Expenditures | $4.7M | $9.8M | $7M | $19.8M | -- | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -$6.3M | -$8.4M | -$7.1M | -$19.9M | -- | |
Dividends Paid (Ex Special Dividend) | -- | -- | -$1.5M | -$2.2M | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | $30.5M | -- | $9M | $76M | -- | |
Long-Term Debt Repaid | -$25.3M | -$1.2M | -$19M | -$78.4M | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -$274K | $5.8M | -- | |
Cash From Financing | $5.2M | -$1.2M | -$11.9M | $1.1M | -- | |
Beginning Cash (CF) | $12.9M | $24.3M | $12.8M | $20.6M | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $2.2M | $39.2M | $36M | $17.2M | -- | |
Ending Cash (CF) | $15.1M | $63.4M | $48.9M | $37.8M | -- | |
Levered Free Cash Flow | -$1.4M | $39M | $48.1M | $16.1M | -- |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$133.5M | -$30.1M | -$3.7M | $12.4M | -$12.7M | |
Depreciation & Amoritzation | $74M | $71.4M | $65.7M | $67.4M | $69.8M | |
Stock-Based Compensation | $4.9M | $10.7M | $7.4M | $6.7M | $9.2M | |
Change in Accounts Receivable | $8.2M | -$14.3M | $1.3M | $6.3M | -$4.8M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -$64.9M | $65.7M | $79M | $95.3M | $83.7M | |
Capital Expenditures | $12.9M | $22.1M | $39.2M | $45.3M | $86.8M | |
Cash Acquisitions | -$28K | -- | -- | -$4.1M | -- | |
Cash From Investing | $660K | $5.2M | -$6.8M | -$48M | -$83.9M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -$4.6M | -$8.1M | -$8.8M | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $263.8M | $171.2M | $107M | $14M | $283M | |
Long-Term Debt Repaid | -$294M | -$229.3M | -$183.1M | -$43.6M | -$280.4M | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -$24.1M | -- | -- | -- | -- | |
Cash From Financing | -$54.1M | -$59.6M | -$83.7M | -$39.6M | -$4.6M | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$118.4M | $11.4M | -$11.4M | $7.7M | -$4.8M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | -$77.8M | $43.6M | $39.8M | $50M | -$3.1M |
Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$51.5M | -$5.9M | $4M | -$32.1M | -$16.8M | |
Depreciation & Amoritzation | $36.5M | $34M | $31.9M | $32.7M | $17.8M | |
Stock-Based Compensation | $4.2M | $4.6M | $3.7M | $4.9M | $3.5M | |
Change in Accounts Receivable | -$31K | $7M | $895K | -$747K | $3.2M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -$9.7M | $55.2M | $47.3M | $20.9M | -$35.3M | |
Capital Expenditures | $6.2M | $16.3M | $15.9M | $35.3M | $23M | |
Cash Acquisitions | -- | -- | -- | -$4.1M | -- | |
Cash From Investing | -$3.7M | -$11.5M | -$16.6M | -$40.6M | -$22.8M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -$3.1M | -$4.4M | -$2.2M | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | $66.5M | $22M | $38M | $81M | $69M | |
Long-Term Debt Repaid | -$52.2M | -$25M | -$40M | -$84.4M | -$29.9M | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -$4K | -- | -$874K | $5.8M | -- | |
Cash From Financing | $14.5M | -$4.4M | -$6.3M | -$2.3M | $29.3M | |
Beginning Cash (CF) | $27M | $48.3M | $37.3M | $80.4M | $44.6M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $1M | $39.4M | $24.3M | -$22.1M | -$28.9M | |
Ending Cash (CF) | $28M | $87.7M | $61.7M | $58.3M | $15.7M | |
Levered Free Cash Flow | -$15.9M | $38.9M | $31.4M | -$14.4M | -$58.3M |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.